Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia
Open Access
- 7 June 2005
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 93 (2) , 260-265
- https://doi.org/10.1038/sj.bjc.6602658
Abstract
Epidemiological studies have consistently shown elevated rates of breast cancer among female blood relatives of patients with ataxia telangiectasia (AT), a rare autosomal recessive disease. A large proportion of the members of AT families are carriers of AT-causing gene mutations in ATM (Ataxia Telangiectasia Mutated), and it has been hypothesised that these otherwise healthy carriers are predisposed to breast cancer. This is an extended and enlarged follow-up study of cancer incidence in blood relatives of 75 patients with verified AT in 66 Nordic families. Blood relatives were identified through population registry linkages, and the occurrence of cancer was determined from cancer registry files in each country and compared with national incidence rates. The ATM mutation carrier probabilities of relatives were assigned from the combined information on location in family, consanguinity, if any, and supplementary carrier screening in some families. Among the 1445 blood relatives of AT patients, 225 cancers were observed, with 170.4 expected, yielding a standardised incidence ratio (SIR) of 1.3 (95% confidence interval (CI), 1.1–1.4). Invasive breast cancer occurred in 34 female relatives (SIR, 1.7; 95% CI, 1.2–2.4) and was diagnosed in 21 women before the age of 55 years (SIR, 2.9; 95% CI, 1.8–4.5), including seven mothers of probands (SIR, 8.1; 95% CI, 3.3–17). When the group of mothers was excluded, no clear relationship was observed between the allocated mutation carrier probability of each family member and the extent of breast cancer risk. We concluded that the increased risk for female breast cancer seen in 66 Nordic AT families appeared to be restricted to women under the age of 55 years and was due mainly to a very high risk in the group of mothers. The findings of breast cancer risk in mothers, but not other likely mutation carriers, in this and other studies raises questions about the hypothesis of a simple causal relationship with ATM heterozygosity.Keywords
This publication has 19 references indexed in Scilit:
- Cervical cancer and microchimerismPublished by Wolters Kluwer Health ,2003
- Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancerHuman Mutation, 2003
- Cancer risk in heterozygotes for ataxia-telangiectasiaInternational Journal of Cancer, 2001
- Characterization ofATM mutations in 41 Nordic families with Ataxia TelangiectasiaHuman Mutation, 2000
- Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancerCancer Genetics and Cytogenetics, 1996
- Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries.BMJ, 1993
- Incidence of Cancer in 161 Families Affected by Ataxia–TelangiectasiaNew England Journal of Medicine, 1991
- Age at first birth, parity and risk of breast cancer: A meta‐analysis of 8 studies from the nordic countriesInternational Journal of Cancer, 1990
- Ataxia-telangiectasia and hepatocellular carcinomaThe Lancet Healthy Longevity, 1979
- 202. Note: Significance Factors for the Ratio of a Poisson Variable to Its ExpectationPublished by JSTOR ,1964